35 U S C 271 E 2 C Ii Cases in Federal Circuit

Browse 1 35 u s c 271 e 2 c ii cases decided by Federal Circuit. AI-powered summaries, holdings, and legal analysis.

1
Cases
1
Plaintiff Win

35 U S C 271 E 2 C Ii Opinions from Federal Circuit (1)

Incyte Corporation v. Sun Pharmaceutical Industries, Ltd.

CAFC Affirms Biosimilar Infringement Finding for Ruxolitinib Patents

Federal Circuit · 2025-05-07 · Plaintiff Win · Impact: 65/100

Incyte Corporation v. Sun Pharmaceutical Industries, Ltd., decided by Federal Circuit on May 7, 2025, resulted in a plaintiff win outcome. The core dispute centered on whether Sun Pharma's proposed bi...

Frequently Asked Questions

Q: How many 35 u s c 271 e 2 c ii cases has Federal Circuit decided?

CaseLawBrief currently tracks 1 35 u s c 271 e 2 c ii cases from Federal Circuit. This number is updated as new opinions are published.

Q: What types of outcomes occur in 35 u s c 271 e 2 c ii cases at Federal Circuit?

Outcome breakdown: Plaintiff Win: 1.

Q: Where can I find plain English summaries of 35 u s c 271 e 2 c ii rulings from Federal Circuit?

Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.

Explore More

All Federal Circuit Cases All 35 U S C 271 E 2 C Ii Cases All Courts All Topics Search